Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease

Mov Disord. 2014 Feb;29(2):275-6. doi: 10.1002/mds.25504. Epub 2013 May 21.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiparkinson Agents / economics*
  • Antiparkinson Agents / therapeutic use
  • Cost of Illness*
  • Deep Brain Stimulation / methods*
  • Female
  • Humans
  • Male
  • Parkinson Disease / economics
  • Parkinson Disease / therapy*
  • Severity of Illness Index
  • Subthalamic Nucleus / physiology*

Substances

  • Antiparkinson Agents